Ravikumar Namita, Bansal Arun
Division of Pediatric Critical Care, Department of Paediatrics, Advanced Paediatrics Centre, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
Transl Pediatr. 2021 Oct;10(10):2792-2798. doi: 10.21037/tp-21-5.
In this review, we address a few key issues and the challenges faced in the management of severe diabetic ketoacidosis (DKA) in children, highlighting the existing standard of care, supported by evidence and bench studies.
The classic triad of DKA namely hyperglycemia, metabolic acidosis and ketonemia warrants immediate attention with fluids and insulin. Correction of dehydration in DKA is of utmost priority and the calculation of fluid volume and choice of fluid have remained a matter of debate. Insulin therapy, to halt the ketone production, in DKA has undergone wide variations in dose and preparation since its discovery. Although the mortality due to severe DKA has remarkably decreased, complications like cerebral edema and acute kidney injury (AKI) continue to haunt the intensivists and endocrinologists on a few occasions.
We have selected a few important questions in the management of severe DKA in children, addressing the challenges, reviewing the studies, guidelines and bedside practices with evidence in this narrative review.
The focus of management should be to understand and normalise the deranged physiology rather than trying to get normal laboratory reports. This needs careful understanding of the pathogenesis and deriving conclusion from bench studies. With newer studies and evidence, guidelines are revised every few years. There is a trend towards more conservative therapy, with continuous and advanced monitoring. Switching to subcutaneous insulin and oral hydration is done as early as possible with clinical monitoring and resolution of DKA. Management of severe DKA in children can vary from simple fluid titration and insulin infusion in mild cases to a scenario with multiorgan dysfunction requiring intensive monitoring and advanced organ support. Individualisation of therapy to suit the needs with the available evidence and expertise is extremely essential.
在本综述中,我们探讨儿童重症糖尿病酮症酸中毒(DKA)管理中面临的一些关键问题和挑战,强调现有循证和基础研究支持的治疗标准。
DKA的典型三联征,即高血糖、代谢性酸中毒和酮血症,需要立即通过补液和胰岛素治疗。纠正DKA中的脱水是最优先事项,而补液量的计算和液体的选择一直存在争议。自发现以来,用于阻止DKA中酮体生成的胰岛素治疗在剂量和制剂方面经历了很大变化。尽管重症DKA导致的死亡率已显著下降,但脑水肿和急性肾损伤(AKI)等并发症仍不时困扰着重症监护医生和内分泌科医生。
在本叙述性综述中,我们选择了儿童重症DKA管理中的几个重要问题,探讨了挑战,回顾了相关研究、指南和床边实践并给出证据。
管理的重点应是理解并使紊乱的生理状态恢复正常,而不是试图获得正常的实验室报告。这需要仔细理解发病机制并从基础研究中得出结论。随着新研究和证据的出现,指南每隔几年就会修订。目前有一种趋势是采用更保守的治疗方法,并进行持续和高级的监测。一旦临床监测显示DKA得到缓解,应尽早转为皮下胰岛素治疗和口服补液。儿童重症DKA的管理范围可从轻度病例中的简单补液滴定和胰岛素输注,到需要强化监测和高级器官支持的多器官功能障碍情况。根据现有证据和专业知识进行个体化治疗以满足需求极为重要。